Cyclic dinucleotides as anticancer agents
US11427610B2 · kind B2 · utility
1Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2018 |
| Grant date | Aug 30, 2022 |
| Priority date | — |
| Expiry date | Aug 5, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.